A. Wong

4.3k total citations · 1 hit paper
19 papers, 2.3k citations indexed

About

A. Wong is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, A. Wong has authored 19 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 10 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in A. Wong's work include Colorectal Cancer Treatments and Studies (11 papers), Colorectal Cancer Surgical Treatments (8 papers) and Colorectal and Anal Carcinomas (7 papers). A. Wong is often cited by papers focused on Colorectal Cancer Treatments and Studies (11 papers), Colorectal Cancer Surgical Treatments (8 papers) and Colorectal and Anal Carcinomas (7 papers). A. Wong collaborates with scholars based in Canada, United States and Australia. A. Wong's co-authors include Alexander Chan, Charles Erlichman, Shai Fine, T Elhakim, Jean A. Maroun, Rafat Ansari, Evelyn B. Harrison, Walter Kocha, Hans Ulrich Burger and John V. Cox and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

A. Wong

19 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study

2001 882 citations Paulo M. Hoff, Rafat Ansari et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A. Wong Canada	15	2.0k	803	688	335	267	19	2.3k
M. Flesch France	23	1.8k 0.9×	361 0.4×	620 0.9×	339 1.0×	455 1.7×	72	2.6k
Élisabeth Carola France	17	2.2k 1.1×	415 0.5×	852 1.2×	338 1.0×	680 2.5×	58	2.5k
M. J. OʼConnell United States	15	2.5k 1.2×	881 1.1×	809 1.2×	989 3.0×	235 0.9×	31	3.0k
Michael A. Poon United States	8	2.4k 1.2×	1.3k 1.7×	793 1.2×	375 1.1×	214 0.8×	9	2.7k
J J Lokich United States	5	1.4k 0.7×	363 0.5×	486 0.7×	244 0.7×	230 0.9×	6	1.6k
M Krulik France	20	1.4k 0.7×	329 0.4×	571 0.8×	348 1.0×	397 1.5×	115	2.0k
Heung Moon Chang South Korea	27	1.3k 0.7×	816 1.0×	1.2k 1.8×	232 0.7×	100 0.4×	80	2.2k
Kjell Magne Tveit Norway	21	1.3k 0.7×	742 0.9×	547 0.8×	249 0.7×	81 0.3×	49	1.8k
M J O'Connell United States	22	1.4k 0.7×	382 0.5×	567 0.8×	571 1.7×	134 0.5×	46	2.2k
S. Frustaci Italy	22	1.6k 0.8×	531 0.7×	1.4k 2.0×	297 0.9×	90 0.3×	81	2.4k

Countries citing papers authored by A. Wong

Since Specialization

Citations

This map shows the geographic impact of A. Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Wong more than expected).

Fields of papers citing papers by A. Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Wong. The network helps show where A. Wong may publish in the future.

Co-authorship network of co-authors of A. Wong

This figure shows the co-authorship network connecting the top 25 collaborators of A. Wong. A scholar is included among the top collaborators of A. Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Wong. A. Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Yong, Wei Peng, Ross A. Soo, A. Wong, et al.. (2016). RAS/AKT pathway mutations as predictive biomarkers in patients with colorectal cancer treated with the exportin 1 (XPO1) inhibitor selinexor (SEL) – inhibition of nuclear-cytoplasmic translocation of p27 as a mechanism of anti-tumour activity. Annals of Oncology. 27. vi122–vi122. 6 indexed citations

Twelves, Chris, Werner Scheithauer, J. McKendrick, et al.. (2011). Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy. Annals of Oncology. 23(5). 1190–1197. 122 indexed citations

Chan, Alexander, A. Wong, & Daryl A. Jenken. (2010). Preoperative Capecitabine and Pelvic Radiation in Locally Advanced Rectal Cancer—Is it Equivalent to 5-FU Infusion Plus Leucovorin and Radiotherapy?. International Journal of Radiation Oncology*Biology*Physics. 76(5). 1413–1419. 30 indexed citations

Haller, Daniel G., Mace L. Rothenberg, A. Wong, et al.. (2008). Oxaliplatin Plus Irinotecan Compared With Irinotecan Alone as Second-Line Treatment After Single-Agent Fluoropyrimidine Therapy for Metastatic Colorectal Carcinoma. Journal of Clinical Oncology. 26(28). 4544–4550. 40 indexed citations

Chan, Alexander, A. Wong, Daryl A. Jenken, et al.. (2005). Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 61(3). 665–677. 150 indexed citations

Chan, Alexander, A. Wong, Daryl A. Jenken, et al.. (2004). Is postoperative adjuvant chemotherapy necessary in locally advanced rectal cancers after preoperative chemoradiation. International Journal of Radiation Oncology*Biology*Physics. 60(1). S297–S297. 3 indexed citations

Chan, A., et al.. (2004). Is postoperative adjuvant chemotherapy necessary in locally advanced rectal cancers after preoperative chemoradiation. International Journal of Radiation Oncology*Biology*Physics. 60. S297–S297. 2 indexed citations

Maroun, Jean A., et al.. (2004). Chemopredictive diagnostic project in patients (pts) receiving capecitabine (X) or 5-FU/leucovorin (LV) as first-line chemotherapy for metastatic colorectal cancer (MCRC). Journal of Clinical Oncology. 22(14_suppl). 9652–9652. 1 indexed citations

Scheithauer, Werner, J McKendrick, S. Begbie, et al.. (2003). Oral capecitabine as an alternative to i.v. 5-fluorouracil-based adjuvant therapy for colon cancer: safety results of a randomized, phase III trial. Annals of Oncology. 14(12). 1735–1743. 222 indexed citations

10.

Schilsky, Richard L., Jeremey Levin, William H. West, et al.. (2002). Randomized, Open-Label, Phase III Study of a 28-Day Oral Regimen of Eniluracil Plus Fluorouracil Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Therapy in Patients With Metastatic/Advanced Colorectal Cancer. Journal of Clinical Oncology. 20(6). 1519–1526. 32 indexed citations

11.

Hoff, Paulo M., Rafat Ansari, Gerald Batist, et al.. (2001). Comparison of Oral Capecitabine Versus Intravenous Fluorouracil Plus Leucovorin as First-Line Treatment in 605 Patients With Metastatic Colorectal Cancer: Results of a Randomized Phase III Study. Journal of Clinical Oncology. 19(8). 2282–2292. 882 indexed citations breakdown →

12.

Chan, Alexander, A. Wong, James M. Langevin, et al.. (2000). Preoperative chemotherapy and pelvic radiation for tethered or fixed rectal cancer: A phase II dose escalation study. International Journal of Radiation Oncology*Biology*Physics. 48(3). 843–856. 78 indexed citations

13.

Chan, Alexander & A. Wong. (1999). Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma?. International Journal of Radiation Oncology*Biology*Physics. 45(2). 265–270. 63 indexed citations

14.

Chan, Alexander, A. Wong, James M. Langevin, et al.. (1997). “Sandwich” preoperative and postoperative combined chemotherapy and radiation in tethered and fixed rectal cancer: Impact of treatment intensity on local control and survival. International Journal of Radiation Oncology*Biology*Physics. 37(3). 629–637. 26 indexed citations

15.

Wong, A. & Alexander Chan. (1993). Survival benefit of tamoxifen therapy in adenocarcinoma of pancreas. A case-control study. Cancer. 71(7). 2200–2203. 39 indexed citations

16.

Chan, Alexander, et al.. (1993). Preoperative concurrent 5-fluorouracil infusion, mitomycin c and pelvic radiation therapy in tethered and fixed rectal carcinoma. International Journal of Radiation Oncology*Biology*Physics. 25(5). 791–799. 94 indexed citations

17.

Steinberg, Joyce, et al.. (1992). Prognostic factors in patients with metastatic colorectal cancer receiving 5-fluorouracil and folinic acid. European Journal of Cancer. 28(11). 1817–1820. 58 indexed citations

18.

Chan, Alexander, A. Wong, & Keith Arthur. (1989). Concomitant 5-fluorouracil infusion, mitomycin C and radical radiation therapy in esophageal squamous cell carcinoma. International Journal of Radiation Oncology*Biology*Physics. 16(1). 59–65. 44 indexed citations

19.

Erlichman, Charles, Shai Fine, A. Wong, & T Elhakim. (1988). A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.. Journal of Clinical Oncology. 6(3). 469–475. 407 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact